Emergent BioSolutions (EBS) Enterprise Value Growth (1y) (2011 - 2026)
Emergent BioSolutions (EBS) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.01% |
| Mar 31, 2026 | -5.69% |
| Dec 31, 2025 | -98.01% |
| Sep 30, 2025 | -59.34% |
| Jun 30, 2025 | -281.69% |
| Mar 31, 2025 | -93.42% |
| Dec 31, 2024 | 5.46% |
| Sep 30, 2024 | -78.13% |
| Jun 30, 2024 | 19.86% |
| Mar 31, 2024 | 81.64% |
| Dec 31, 2023 | 82.62% |
| Sep 30, 2023 | 63.57% |
| Jun 30, 2023 | 75.27% |
| Mar 31, 2023 | 1.33% |
| Dec 31, 2022 | -11.50% |
| Sep 30, 2022 | 40.35% |
| Jun 30, 2022 | 19.97% |
| Mar 31, 2022 | 20.44% |
| Dec 31, 2021 | 7.27% |
| Sep 30, 2021 | 2.70% |